Vivo Capital
VC · Palo Alto (United States)
Sign up free to access full profile and submit your pitch.
About
Vivo Capital is a global healthcare investment firm founded in 1996, specializing in investments across venture capital, private equity, and public equity strategies. With approximately $5.8 billion in assets under management, the firm has invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, Vivo Capital also maintains offices in Beijing, Shanghai, Hong Kong, and Taipei. The firm's investment focus spans biopharmaceuticals, specialty pharmaceuticals, medical devices, and healthcare services, primarily targeting the U.S. and East Asia markets, particularly China. Vivo Capital employs a multi-pronged strategy, identifying and collaborating with companies developing and commercializing innovative healthcare products and technologies. The firm's team comprises professionals with backgrounds in medicine, science, and entrepreneurship, enabling effective navigation of the healthcare sector's complexities.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of Vivo Capital
Other investors that have backed the same portfolio companies as Vivo Capital. Expand any entry to see the shared portfolio companies.
- 26 shared
Shared portfolio companies
- Aclaris Therapeutics, Inc.
- Adverum Biotechnologies, Inc.
- Ajax Therapeutics, Inc.
- Arcutis Biotherapeutics, Inc.
- Ascendis Pharma A/S
- Aurinia Pharmaceuticals Inc.
- Avadel Pharmaceuticals plc
- Bolt Biotherapeutics, Inc.
- Cerebral Therapeutics, Inc.
- Coherus Oncology, Inc.
- DBV Technologies S.A.
- Immunic, Inc.
- IO Biotech ApS
- KALA BIO, Inc.
- Kira Pharmaceuticals
- Larimar Therapeutics, Inc.
- Legend Biotech Corporation
- Lite Strategy, Inc.
- MacroGenics, Inc.
- Medeor Therapeutics, Inc.
- Ocelot Bio, Inc.
- Olema Pharmaceuticals, Inc.
- Precision BioSciences, Inc.
- SAB Biotherapeutics, Inc.
- Tourmaline Bio, Inc.
- Unicycive Therapeutics, Inc.
- 23 shared
Shared portfolio companies
- ADARx Pharmaceuticals, Inc.
- Adverum Biotechnologies, Inc.
- Arcutis Biotherapeutics, Inc.
- Ascendis Pharma A/S
- BlossomHill Therapeutics, Inc.
- Compass Therapeutics, Inc.
- GenFleet Therapeutics (Shanghai) Inc.
- KALA BIO, Inc.
- Larimar Therapeutics, Inc.
- MacroGenics, Inc.
- Mereo BioPharma Group plc
- Nabriva Therapeutics plc
- Neurogastrx, Inc.
- Olema Pharmaceuticals, Inc.
- ORIC Pharmaceuticals, Inc.
- Passage Bio, Inc.
- RemeGen, Ltd.
- Sinovac Biotech Ltd.
- Terns Pharmaceuticals, Inc.
- VISEN Pharmaceuticals (Shanghai) Co., Ltd.
- VYNE Therapeutics Inc.
- Whitehawk Therapeutics, Inc.
- Zai Lab Limited
- 12 shared
